Peter de Vries

2.5k total citations
20 papers, 920 citations indexed

About

Peter de Vries is a scholar working on Molecular Biology, Nuclear and High Energy Physics and Biomedical Engineering. According to data from OpenAlex, Peter de Vries has authored 20 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nuclear and High Energy Physics and 6 papers in Biomedical Engineering. Recurrent topics in Peter de Vries's work include Magnetic confinement fusion research (6 papers), Superconducting Materials and Applications (6 papers) and T-cell and B-cell Immunology (4 papers). Peter de Vries is often cited by papers focused on Magnetic confinement fusion research (6 papers), Superconducting Materials and Applications (6 papers) and T-cell and B-cell Immunology (4 papers). Peter de Vries collaborates with scholars based in United States, France and Germany. Peter de Vries's co-authors include Jack W. Singer, Eugene Maraskovsky, Stewart D. Lyman, M P Beckmann, Tim Vanden Bos, Douglas E. Williams, Kathleen S. Picha, Frederick A. Fletcher, Hilary J. McKenna and Ken Brasel and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Peter de Vries

18 papers receiving 884 citations

Peers

Countries citing papers authored by Peter de Vries

Since Specialization

Citations

This map shows the geographic impact of Peter de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter de Vries more than expected).

Fields of papers citing papers by Peter de Vries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter de Vries. The network helps show where Peter de Vries may publish in the future.

Co-authorship network of co-authors of Peter de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Peter de Vries. A scholar is included among the top collaborators of Peter de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter de Vries. Peter de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	ITER ECH&CD Control System: Architecture, interfaces and status of development	SHILAP Revista de lepidopterología	G. Carannante, M. Cavinato et al.	2
2	Strategy towards model-based design and testing of the ITER Plasma Control System	Fusion Engineering and Design	T. Ravensbergen, L. Zabeo et al.	14
3	Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models	Molecular Cancer Therapeutics	Anita Kulukian, Patrice Lee et al.	144
4	Introduction to Tokamak Plasma Control		M.L. Walker, Peter de Vries et al.	18
5	Assessment of controllers and scenario control performance for ITER first plasma	Fusion Engineering and Design	M.L. Walker, A.S. Welander et al.	10
6	Experiences With Tungsten Plasma Facing Components in ASDEX Upgrade and JET	IEEE Transactions on Plasma Science	R. Neu, S. Brezinsek et al.	25
7	MHD instabilities in JET Hybrid Scenario with the ITER Like Wall	Bulletin of the American Physical Society	M. Baruzzo, T. Bolzonella et al.	0
8	Quality in E-learning: user experiences in China	University of Twente Research Information	Sjoerd de Vries, Peter de Vries et al.	0
9	Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib	Clinical Cancer Research	Paul La Rosée, Taiping Jia et al.	23
10	Synthesis, SAR, and antitumor properties of diamino- C , N -diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-β	Bioorganic & Medicinal Chemistry Letters	Baoqing Gong, Feng Hong et al.	23
11	Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate	Advances in experimental medicine and biology	Jack W. Singer, Brian Baker et al.	124
12	Lysophosphatidic acid acyltransferase-β: a novel target for induction of tumour cell apoptosis	Expert Opinion on Therapeutic Targets	Lynn Bonham, David W. M. Leung et al.	39
13	Lysophosphatidic acid acyltransferase-?: a novel target for induction of tumour cell apoptosis	Expert Opinion on Therapeutic Targets	Lynn Bonham, David W. M. Leung et al.	1
14	B Cells Express Ly-6C in a Th1 but Not Th2 Cytokine Environment	Journal of Interferon & Cytokine Research	Annette J. Schlueter, Arthur Μ. Krieg et al.	8
15	Type I Interferon Is the Primary Regulator of Inducible Ly-6C Expression on T Cells	Journal of Interferon & Cytokine Research	Annette J. Schlueter, Arthur Μ. Krieg et al.	20
16	Delineation among eight major hematopoietic subsets in murine bone marrow using a two-color flow cytometric technique	Cytometry	Annette J. Schlueter, Sudershan K. Bhatia et al.	5
17	Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents	Experimental Hematology	Peter de Vries, Jack W. Singer	14
18	Efficient Calculation of Solute Transport in Heterogeneous Soils Exhibiting Non‐Richards‐Type Unsaturated Flow	Journal of Environmental Quality	Gerrit H. de Rooij, Peter de Vries	5
19	Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells	Cell	Stewart D. Lyman, Tim Vanden Bos et al.	444
20	Identification of murine haemopoietic stem cells with monoclonal antibodies		Peter de Vries	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact